Cost-effectiveness analysis of imaging surveillance in stage II and III extremity soft tissue sarcoma: an Australian perspective
- PMID: 32042270
- PMCID: PMC6998821
- DOI: 10.1186/s12962-020-0202-7
Cost-effectiveness analysis of imaging surveillance in stage II and III extremity soft tissue sarcoma: an Australian perspective
Abstract
Background: Surveillance imaging is used to detect local and/or distant recurrence following primary treatment of localised soft tissue sarcoma (STS), however evidence supporting optimal surveillance modality or frequency is lacking. We used prospectively collected sarcoma data to describe current surveillance imaging practice in patients with AJCC stage II and III extremity STS and evaluate its cost-effectiveness.
Methods: From three selected Australian sarcoma referral centres, we identified patients with stage II and III extremity STS treated between 2009 and 2013. Medical records were reviewed to ascertain surveillance imaging practices, including modality, frequency and patient outcomes. A discrete event simulation model was developed and calibrated using clinical data to estimate health service costs and quality adjusted life years (QALYs) associated with alternative surveillance strategies.
Results: Of 133 patients treated for stage II and III extremity STS, the majority were followed up with CT chest (86%), most commonly at 3-monthly intervals and 62% of patients had the primary site imaged with MRI at 6-monthly. There was limited use of chest-X-ray. A discrete event simulation model demonstrated that CT chest screening was the most cost effective surveillance strategy, gaining additional QALYs at a mean incremental cost of $30,743. MRI alone and PET-CT alone were not cost-effective, whilst a combined strategy of CT + MRI had an incremental cost per QALY gained of $96,556.
Conclusions: Wide variations were observed in surveillance imaging practices in this high-risk STS cohort. Modelling demonstrated the value of CT chest for distant recurrence surveillance over other forms of imaging in terms of cost and QALYs. Further work is required to evaluate cost-effectiveness in a prospective manner.
Keywords: Cost-effectiveness; Disease recurrence; Distant recurrence; Imaging surveillance; Local recurrence; Metastasectomy; Pulmonary metastases; Soft tissue sarcoma.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Figures
Similar articles
-
Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma.Ann Surg Oncol. 2017 Oct;24(11):3264-3270. doi: 10.1245/s10434-017-5996-y. Epub 2017 Jul 17. Ann Surg Oncol. 2017. PMID: 28718037
-
Effective follow-up strategies in soft tissue sarcoma.Semin Surg Oncol. 1999 Jul-Aug;17(1):83-7. doi: 10.1002/(sici)1098-2388(199907/08)17:1<83::aid-ssu11>3.0.co;2-w. Semin Surg Oncol. 1999. PMID: 10402642
-
The value of re-staging chest CT at first local recurrence of extremity and trunk soft tissue sarcoma.Eur Radiol. 2021 Apr;31(4):2377-2383. doi: 10.1007/s00330-020-07366-8. Epub 2020 Oct 10. Eur Radiol. 2021. PMID: 33037910
-
Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.Ann Surg. 2003 Apr;237(4):544-55. doi: 10.1097/01.SLA.0000059989.55280.33. Ann Surg. 2003. PMID: 12677152 Free PMC article. Review.
-
Short-Term and Long-Term Management of Melanoma.In: Ward WH, Farma JM, editors. Cutaneous Melanoma: Etiology and Therapy [Internet]. Brisbane (AU): Codon Publications; 2017 Dec 21. Chapter 11. In: Ward WH, Farma JM, editors. Cutaneous Melanoma: Etiology and Therapy [Internet]. Brisbane (AU): Codon Publications; 2017 Dec 21. Chapter 11. PMID: 29461775 Free Books & Documents. Review.
Cited by
-
Discrete-Event Simulation Modeling in Healthcare: A Comprehensive Review.Int J Environ Res Public Health. 2021 Nov 22;18(22):12262. doi: 10.3390/ijerph182212262. Int J Environ Res Public Health. 2021. PMID: 34832016 Free PMC article. Review.
-
Linear mixed-effects models for predicting sarcoma local recurrence growth rates: Implications for optimal surveillance imaging frequency.Eur J Radiol. 2020 Nov;132:109308. doi: 10.1016/j.ejrad.2020.109308. Epub 2020 Sep 28. Eur J Radiol. 2020. PMID: 33010684 Free PMC article.
-
Surveillance Post Surgery for Retroperitoneal Soft Tissue Sarcoma.Curr Oncol. 2023 Feb 26;30(3):2781-2791. doi: 10.3390/curroncol30030211. Curr Oncol. 2023. PMID: 36975424 Free PMC article. Review.
-
Beyond Clinical Examination: Utilizing MRI Surveillance to Detect Recurrence of Soft Tissue Sarcomas and Differentiate from Posttherapeutic Changes.Biomedicines. 2024 Jul 23;12(8):1640. doi: 10.3390/biomedicines12081640. Biomedicines. 2024. PMID: 39200105 Free PMC article.
-
A Scoping Review on Calibration Methods for Cancer Simulation Models.Med Decis Making. 2025 Aug 11:272989X251353211. doi: 10.1177/0272989X251353211. Online ahead of print. Med Decis Making. 2025. PMID: 40790869 Free PMC article. Review.
References
-
- National Comprehensive Cancer Network. Soft Tissue Sarcoma (Version 1.2018). http://nlmsf.org/wp-content/uploads/2018/03/NCCNsarcoma-guidelines-for-p.... Accessed 1 Dec 2018.
LinkOut - more resources
Full Text Sources